A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)	Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	Recruiting	Phase 3	2026-10-07		NCT06338995

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370

200 results · Page 1 of 8

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
1-8-1, Kishinoura	Kitakyushu	Japan	1
3-54-2, Kotohirahommachi	Kumamoto	Japan	1
8-2 Otemachi	Shizuoka	Japan	1
Aalborg Universitetshospital Medicinerhuset Lungemedicinsk Forskningsenhed	Aalborg	Denmark	1
Aarhus University Hospital, Dept. of Ear-Nose-Throat	Aarhus	Denmark	1
ADCRC	La Mesa	United States	1
Ajou University Hospital	Suwon	South Korea	40
Alamo ENT Associates	San Antonio	United States	1
Alina Clinical Trials	Dallas	United States	1
AllerVie Clinical Research	Birmingham	United States	14
AOU Careggi- University of Florence	Florence	Italy	1
AOU Federico II Via Pansini	Naples	Italy	1
Ark Clinical Research	Long Beach	United States	20
Asahioka, 1-24	Niigata	Japan	1
ASST Brianza - Vimercate Hospital	Vimercate	Italy	1
Avenida Independencia	Aguascalientes	Mexico	1
Azienda Ospedaliera Di Padova	Padova	Italy	16
Azienda Ospedaliero Universitaria Pisana - Stabilimento Santa Chiara	Pisa	Italy	4
B&R Clinical Sp. z o.o	Kielce	Poland	1
Beijing Hospital	Beijing	China	14
Beijing Tongren Hospital	Beijing	China	4
Bioresearch Partner-Kendale Lakes	Miami	United States	2
Bispebjerg Hospital Department of Respiratory Medicine	Copenhagen	Denmark	1
Breathe Clear Institute	Torrance	United States	6
Brigham and Women's Hospital	Boston	United States	60

Clinical trials